This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA
Book Now
Menu
Book

Cecilia Fernández, Ph.D.
Entrepreneur in Residence at Mass General Brigham Ventures
Speaker

Agenda Sessions

  • Co-Chairs': Genome Editing Preclinical and Clinical Updates: Part 1

    , 8:25am
    View Session

At this event

Prev
Next
Mike Flanagan, PhD
Chief Scientific Officer
Avidity Biosciences

See Cecilia at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now